journal article·2024-07-03

A “Ferroptosis-Amplifier” Hydrogel for Eliminating Refractory Cancer Stem Cells Post-lumpectomy

Yutong Zhu, Xi Deng, Zideng Dai, Qing Liu, Yichen Kuang, Tianzhi Liu, Hangrong Chen

Nano Letters· Volume 24· Issue 26
Publisher page

Abstract

The unique “Iron Addiction” feature of cancer stem cells (CSCs) with tumorigenicity and plasticity generally contributes to the tumor recurrence and metastasis after a lumpectomy. Herein, a novel “Ferroptosis Amplification” strategy is developed based on integrating gallic acid-modified FeOOH (GFP) and gallocyanine into Pluronic F-127 (F127) and carboxylated chitosan (CC)-based hydrogel for CSCs eradication. This “Ferroptosis Amplifier” hydrogel is thermally sensitive and achieves rapid gelation at the postsurgical wound in a breast tumor model. Specifically, gallocyanine, as the Dickkopf-1 (DKK1) inhibitor, can decrease the expression of SLC7A11 and GPX4 and synergistically induce ferroptosis of CSCs with GFP. Encouragingly, it is found that this combination suppresses the migratory and invasive capability of cancer cells via the downregulation of matrix metalloproteinase 7 (MMP7). The in vivo results further confirm that this “Ferroptosis Amplification” strategy is efficient in preventing tumor relapse and lung metastasis, manifesting an effective and promising postsurgical treatment for breast cancer.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Cancer Cells and Metastasis · Ferroptosis and cancer prognosis · Epigenetics and DNA Methylation

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

State Key Laboratory of High Performance Ceramics and Superfine Microstructures, Shanghai Institute of Ceramics, Chinese Academy of Sciences, Shanghai 200050, P.R. China

Center of Materials Science and Optoelectronics Engineering, University of Chinese Academy of Sciences, Beijing 100049, P. R. China

School of Chemistry and Materials Science, Hangzhou Institute for Advanced Study, University of Chinese Academy of Sciences, Hangzhou 310024, P. R. China

Funding

National Key Research and Development Program of China · Shanghai Municipal People's Government · Science and Technology Commission of Shanghai Municipality · National Natural Science Foundation of China · Shanghai Municipality

References (33)

Show source-provided references
1. 10.1038/s41523-022-00468-010.1038/s41523-022-00468-0 ↗
2. 10.1007/s10549-016-4059-610.1007/s10549-016-4059-6 ↗
3. 10.3390/cancers1324620910.3390/cancers13246209 ↗
4. 10.3389/fmed.2017.0022710.3389/fmed.2017.00227 ↗
5. 10.1038/nature1262410.1038/nature12624 ↗
6. 10.1038/3510216710.1038/35102167 ↗
7. 10.1002/advs.20220127110.1002/advs.202201271 ↗
8. 10.1016/j.ejso.2015.12.00810.1016/j.ejso.2015.12.008 ↗
9. 10.1016/j.semcancer.2017.02.01110.1016/j.semcancer.2017.02.011 ↗
10. 10.1016/j.actbio.2022.04.01710.1016/j.actbio.2022.04.017 ↗
11. 10.1038/s41565-020-00793-010.1038/s41565-020-00793-0 ↗
12. 10.1016/j.lfs.2021.11966710.1016/j.lfs.2021.119667 ↗
13. 10.1038/s41392-020-0110-510.1038/s41392-020-0110-5 ↗
14. 10.1016/j.nantod.2024.10220710.1016/j.nantod.2024.102207 ↗
15. 10.3390/cells1011298110.3390/cells10112981 ↗
16. 10.3389/fonc.2023.125156110.3389/fonc.2023.1251561 ↗
17. 10.1158/0008-5472.CAN-21-056710.1158/0008-5472.CAN-21-0567 ↗
18. 10.1021/acsnano.9b0174010.1021/acsnano.9b01740 ↗
19. 10.1021/acsnano.3c1196010.1021/acsnano.3c11960 ↗
20. 10.1002/adfm.20231354010.1002/adfm.202313540 ↗
21. 10.1016/j.apmt.2021.10123510.1016/j.apmt.2021.101235 ↗
22. 10.2147/CMAR.S27517210.2147/CMAR.S275172 ↗
23. 10.1186/1476-4598-12-15710.1186/1476-4598-12-157 ↗
24. 10.1038/s41467-022-29018-910.1038/s41467-022-29018-9 ↗
25. 10.1002/smll.20200135610.1002/smll.202001356 ↗
26. 10.1016/j.actbio.2023.02.01510.1016/j.actbio.2023.02.015 ↗
27. 10.1002/adma.20230516210.1002/adma.202305162 ↗
28. 10.1007/s12274-024-6455-210.1007/s12274-024-6455-2 ↗
29. 10.1038/s41467-021-23710-y10.1038/s41467-021-23710-y ↗
30. 10.1002/adfm.20220687610.1002/adfm.202206876 ↗
31. 10.1021/acs.nanolett.2c0134610.1021/acs.nanolett.2c01346 ↗
32. 10.1016/j.redox.2021.10195310.1016/j.redox.2021.101953 ↗
33. 10.1016/j.clinbiochem.2021.03.00310.1016/j.clinbiochem.2021.03.003 ↗